Literature DB >> 22221075

Prospective trial comparing transrectal ultrasonography and transurethral seminal vesiculoscopy for persistent hematospermia.

Changyong Xing1, Xiaomei Zhou, Lei Xin, Hongzhen Hu, Liping Li, Jingchuan Fang, Zhiyong Liu.   

Abstract

OBJECTIVE: To compare the diagnostic yield of transrectal ultrasonography and transurethral seminal vesiculoscopy in patients with persistent hematospermia, and to determine the advantages and disadvantages of both modalities.
METHODS: We prospectively enrolled 106 patients with persistent hematospermia of mean duration 20.5 months. All patients were evaluated by both transrectal ultrasonography and transurethral seminal vesiculoscopy after excluding definite etiological lesions beyond the reproductive duct system. The diagnostic yield and other technical parameters of both modalities were compared.
RESULTS: Final diagnoses were made in 93 patients (87.7%), with transrectal ultrasonography and transurethral seminal vesiculoscopy showing overall diagnostic yields of 45.3% and 74.5%, respectively (P < 0.001). The diagnostic yield of combining transrectal ultrasonography and transurethral seminal vesiculoscopy was significantly higher than that of each modality alone (both P < 0.001). Of the 114 findings of diagnostic value, the most frequent was calculus (47.4%, n = 54), followed by obstruction/stricture (37.7%, n = 43), cyst (8.8%, n = 10), dysplasia (3.5%, n = 4), polyp (1.8%, n = 2) and benign mass (0.9%, n = 1). Transurethral seminal vesiculoscopy showed significant superiority in detecting calculi and obstruction/stricture. Hematospermia disappeared in 95.3% (101/106) of all patients and in 97.6% (83/85) of patients receiving transurethral seminal vesiculoscopy therapy during follow up. No major adverse effects occurred during and after examination.
CONCLUSIONS: The diagnostic yield of transurethral seminal vesiculoscopy for persistent hematospermia was significantly superior to that of transrectal ultrasonography, especially in lesions diagnosed with calculi and obstruction/stricture. Combining both modalities might provide extra benefits for patients with persistent hematospermia.
© 2012 The Japanese Urological Association.

Entities:  

Mesh:

Year:  2012        PMID: 22221075     DOI: 10.1111/j.1442-2042.2011.02952.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  11 in total

Review 1.  Hematospermia-a Symptom With Many Possible Causes.

Authors:  Michael J Mathers; Stefan Degener; Herbert Sperling; Stephan Roth
Journal:  Dtsch Arztebl Int       Date:  2017-03-17       Impact factor: 5.594

2.  Intraoperative calculus or hemorrhage in transurethral seminal vesiculoscopy as a risk factor for recurrent hemospermia.

Authors:  Cheng-En Mei; Ju-Chuan Hu; Jian-Ri Li; Kun-Yuan Chiu; Shian-Shiang Wang; Chuan-Shu Chen
Journal:  PLoS One       Date:  2022-07-05       Impact factor: 3.752

Review 3.  Etiology, Diagnosis, and Management of Seminal Vesicle Stones.

Authors:  Saher Zaidi; Jason Gandhi; Omar Seyam; Gunjan Joshi; Wayne C Waltzer; Noel L Smith; Sardar Ali Khan
Journal:  Curr Urol       Date:  2019-05-10

4.  Clinical outcome of treating intractable hematospermia using holmium laser incision through a ureteroscope.

Authors:  Xiao-Jun Wu; Heng Zhang; Yong-Quan Wang; Yi Zhi; Ji Zheng; Peng He; Wei-Bing Li; Zhan-Song Zhou
Journal:  Asian J Androl       Date:  2016 Jan-Feb       Impact factor: 3.285

5.  Transurethral seminal vesiculoscopy for recurrent hemospermia: experience from 419 cases.

Authors:  Rui Chen; Lei Wang; Xia Sheng; Shu-Guang Piao; Xin-Wen Nian; Xin Cheng; Tie Zhou; Hui-Zhen Li; Ya-Wei Liu; Guang-Hua Chen; Chun-Lei Zhang; De-Pei Kong; Guang-An Xiao; Xin Lu; Zhen-Yu Jia; Zhi-Yong Liu; Ying-Hao Sun
Journal:  Asian J Androl       Date:  2018 Sep-Oct       Impact factor: 3.285

Review 6.  Retrograde ejaculation, painful ejaculation and hematospermia.

Authors:  Arie Parnham; Ege Can Serefoglu
Journal:  Transl Androl Urol       Date:  2016-08

7.  Guiding role of seminal tract anatomical study in transurethral seminal vesiculoscopy.

Authors:  Kun Pang; Wen Yang; Jianjun Zhang; Longjun Cai; Bo Chen; Zhiguo Zhang; Lin Hao; Zhenduo Shi; Bo Jiang; Changjie Ouyang; Dewei Qu; Deguang Wang; Conghui Han; Wenda Zhang
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2019-07-22       Impact factor: 1.195

8.  Transurethral resection of ejaculatory duct combined with seminal vesiculoscopy for management of persistent or recurrent hemospermia in men with ejaculatory duct obstruction.

Authors:  Zheng-Ju Ren; Bo Yang; Dong-Liang Lu; Sheng-Zhuo Liu; Lu-Chen Yang; Lin Cun Wang; Zhu-Feng Peng; Liang-Ren Liu; Qiang Dong
Journal:  BMC Urol       Date:  2020-03-23       Impact factor: 2.264

9.  Real-time transrectal ultrasound-guided seminal vesiculoscopy for the treatment of patients with persistent hematospermia: A single-center, prospective, observational study.

Authors:  Xue-Sheng Wang; Ming Li; Guang-Feng Shao; Wen-Dong Sun; Xiu-Lin Zhang; Zhi-Ying Xiao; Zhen Ma; Ming-Zhen Yuan; Li-Qiang Guo
Journal:  Asian J Androl       Date:  2020 Sep-Oct       Impact factor: 3.285

10.  Successful treatment of seminal vesicle calculi and prostatic utricle calculi by transurethral seminal vesiculoscopy.

Authors:  Liming Song; Hu Han; Hongen Lei; Yun Cui; Sujuan Feng; Xiaodong Zhang; Long Tian
Journal:  Andrologia       Date:  2020-08-26       Impact factor: 2.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.